Form 8-K - Current report:
SEC Accession No. 0001193125-24-188937
Filing Date
2024-07-30
Accepted
2024-07-30 16:46:03
Documents
18
Period of Report
2024-07-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d869824d8k.htm   iXBRL 8-K 28899
2 EX-99.1 d869824dex991.htm EX-99.1 176830
7 GRAPHIC g869824g12q95.jpg GRAPHIC 6879
8 GRAPHIC g869824g41q22.jpg GRAPHIC 5903
9 GRAPHIC g869824g88v87.jpg GRAPHIC 9413
  Complete submission text file 0001193125-24-188937.txt   415144

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dbvt-20240730.xsd EX-101.SCH 3100
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dbvt-20240730_def.xml EX-101.DEF 13866
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dbvt-20240730_lab.xml EX-101.LAB 22897
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dbvt-20240730_pre.xml EX-101.PRE 14704
20 EXTRACTED XBRL INSTANCE DOCUMENT d869824d8k_htm.xml XML 5886
Mailing Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320
Business Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320 33(0)155427878
DBV Technologies S.A. (Filer) CIK: 0001613780 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36697 | Film No.: 241158257
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)